tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BIIB Stock Latest News

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
Press ReleasesEisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
6h ago
BIIB
Biogen price target raised to $342 from $339 at HSBC
PremiumThe Fly
Biogen price target raised to $342 from $339 at HSBC
12d ago
BIIB
Biogen reports progress on Corporate Responsibility Priorities
PremiumThe Fly
Biogen reports progress on Corporate Responsibility Priorities
13d ago
BIIB
Biogen Reports Progress on Corporate Responsibility Priorities
PremiumPress Releases
Biogen Reports Progress on Corporate Responsibility Priorities
13d ago
BIIB
Sage Therapeutics price target lowered to $15 from $26 at RBC Capital
PremiumThe Fly
Sage Therapeutics price target lowered to $15 from $26 at RBC Capital
19d ago
BIIB
SAGE
Biogen announces CHMP opinion recommending Tofidence
PremiumThe FlyBiogen announces CHMP opinion recommending Tofidence
19d ago
BIIB
Biogen receives positive CHMP opinion for TOFIDENCE
PremiumThe Fly
Biogen receives positive CHMP opinion for TOFIDENCE
19d ago
BIIB
Sage Therapeutics price target lowered to $18 from $22 at Truist
PremiumThe Fly
Sage Therapeutics price target lowered to $18 from $22 at Truist
19d ago
BIIB
SAGE
Biogen price target raised to $215 from $213 at Wedbush
PremiumThe Fly
Biogen price target raised to $215 from $213 at Wedbush
20d ago
BIIB
Biogen price target lowered to $250 from $260 at BofA
PremiumThe Fly
Biogen price target lowered to $250 from $260 at BofA
20d ago
BIIB
Biogen price target lowered to $300 from $325 at H.C. Wainwright
PremiumThe Fly
Biogen price target lowered to $300 from $325 at H.C. Wainwright
20d ago
BIIB
Biogen price target raised to $308 from $305 at Canaccord
PremiumThe Fly
Biogen price target raised to $308 from $305 at Canaccord
20d ago
BIIB
Biogen price target lowered to $200 from $215 at Barclays
PremiumThe FlyBiogen price target lowered to $200 from $215 at Barclays
20d ago
BIIB
Biogen backs FY24 adjusted EPS view of $15.00-$16.00, consensus $15.46
PremiumThe Fly
Biogen backs FY24 adjusted EPS view of $15.00-$16.00, consensus $15.46
21d ago
BIIB
Biogen reports Q1 adjusted EPS $3.67, consensus $3.44
PremiumThe Fly
Biogen reports Q1 adjusted EPS $3.67, consensus $3.44
21d ago
BIIB
QQQ ETF Update, 4/24/2024
PremiumMarket News
QQQ ETF Update, 4/24/2024
21d ago
ZS
CEG
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
21d ago
T
BA
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
22d ago
T
BA
QQQ ETF Update, 4/23/2024 
PremiumMarket News
QQQ ETF Update, 4/23/2024 
22d ago
ON
ZS
Biogen Inc. (BIIB) Q1 Earnings Cheat Sheet
PremiumPre-EarningsBiogen Inc. (BIIB) Q1 Earnings Cheat Sheet
23d ago
BIIB
Biogen price target lowered to $270 from $290 at Oppenheimer
PremiumThe Fly
Biogen price target lowered to $270 from $290 at Oppenheimer
26d ago
BIIB
QQQ ETF Update, 4/17/2024 
PremiumMarket News
QQQ ETF Update, 4/17/2024 
28d ago
ON
ZS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >